Searching map area
Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
? TBD
scientific article published on 30 January 2018
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Asher M Marks
Subject
teenager
anaplastic ganglioglioma
References
Wikidata